Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.73 |
| ▸ | FAAH | O00519 | 5/20 | 0.68 |
| ▸ | CASP2 | P42575 | 1/20 | 0.66 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.64 |
| ▸ | NAAA | Q02083 | 1/20 | 0.61 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.57 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.53 |
| ▸ | SELP | P16109 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL117118 | 1.00 | SLC6A5 (0.73) | SLC6A5FAAHCASP2DNM1NAAA | |
| SCHEMBL19861379 | 1.00 | SLC6A5 (0.73) | SLC6A5FAAHCASP2DNM1NAAA | |
| SCHEMBL6896450 | 1.00 | SLC6A5 (0.73) | SLC6A5FAAHCASP2DNM1NAAA | |
| SCHEMBL4662738 | 1.00 | SLC6A5 (0.73) | SLC6A5FAAHCASP2DNM1NAAA | |
| SCHEMBL115770 | 1.00 | SLC6A5 (0.73) | SLC6A5FAAHCASP2DNM1NAAA | |
| SCHEMBL248585 | 1.00 | SLC6A5 (0.73) | SLC6A5FAAHCASP2DNM1NAAA | |
| SCHEMBL115809 | 1.00 | SLC6A5 (0.73) | SLC6A5FAAHCASP2DNM1NAAA | |
| SCHEMBL115688 | 1.00 | SLC6A5 (0.73) | SLC6A5FAAHCASP2DNM1NAAA | |
| Hydrochloric Acid SCHEMBL28641720 | 0.98 | SLC6A5 (0.74) | SLC6A5FAAHCASP2DNM1NAAA | |
| SCHEMBL28470408 | 0.98 | SLC6A5 (0.71) | SLC6A5FAAHCASP2DNM1NAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220249438-A1 | CARBOCYANINE COMPOUNDS FOR TARGETING MITOCHONDRIA AND ERADICATING CANCER STEM CELLS | LUNELLA BIOTECH, INC. (CA) | 2022-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220249438-A1 | CARBOCYANINE COMPOUNDS FOR TARGETING MITOCHONDRIA AND ERADICATING CANCER STEM CELLS | UQCRC1, MT-CO2, UQCRC2 | SLC6A5 3218/4885FAAH 4790/4885CASP2 1076/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.